The DOI matches its Crossref record, with a small difference in title or year; 54 of the 56 references it cites were found in a registry or an index.
Antidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis
Open accessAbstract
CONTEXT: Antidepressant medications represent the best established treatment for major depressive disorder, but there is little evidence that they have a specific pharmacological effect relative to pill placebo for patients with less severe depression. OBJECTIVE: To estimate the relative benefit of medication vs placebo across a wide range of initial symptom severity in patients diagnosed with depression. DATA SOURCES: PubMed, PsycINFO, and the Cochrane Library databases were searched from January 1980 through March 2009, along with references from meta-analyses and reviews. STUDY SELECTION: Randomized placebo-controlled trials of antidepressants approved by the Food and Drug Administration in the treatment of major or minor depressive disorder were selected. Studies were included if their authors provided the requisite original data, they comprised adult outpatients, they included a medication vs placebo comparison for at least 6 weeks, they did not exclude patients on the basis of a placebo washout period, and they used the Hamilton Depression Rating Scale (HDRS). Data from 6 studies (718 patients) were included. DATA EXTRACTION: Individual patient-level data were obtained from study authors. RESULTS: Medication vs placebo differences varied substantially as a function of baseline severity. Among patients with HDRS scores below 23, Cohen d effect sizes for the difference between medication and placebo were estimated to be less than 0.20 (a standard definition of a small effect). Estimates of the magnitude of the superiority of medication over placebo increased with increases in baseline depression severity and crossed the threshold defined by the National Institute for Clinical Excellence for a clinically significant difference at a baseline HDRS score of 25. CONCLUSIONS: The magnitude of benefit of antidepressant medication compared with placebo increases with severity of depression symptoms and may be minimal or nonexistent, on average, in patients with mild or moderate symptoms. For patients with very severe depression, the benefit of medications over placebo is substantial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“antidepressants have been demonstrated efficient in treating MDD”
From SSRI Treatment Response Prediction in Depression Based on Brain Activation by Emotional Stimuli (2020) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fournier and colleagues meta-analysed trials of selective serotonin reuptake inhibitors and estimated the effect size.45 For mild to severe depression the effect estimates ranged from -0.17 to -0.11; this is lower than the effect size for smoking cessation.”
From Change in mental health after smoking cessation: systematic review and meta-analysis (2014) · cites this paper as [45]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For SSRIs, researchers have argued that a substantial portion of the perceived therapeutic benefit in double-blind randomized clinical trials (RCTs) may stem from placebo responses rather than the drug itself (Sugarman et al., 2014; Fournier et al., 2010; Kirsch, 2014; Moncrieff and Kirsch, 2015).”
From Revisiting the SSRI vs. placebo debate in the treatment of social anxiety disorder: the role of expectancy effects, neural responsivity, and monoamine transporters (2025) · cites this paper as Fournier et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The introduction and widespread use of selective serotonine uptake inhibitors (SSRI) [22, 23] and psychological therapy including cognitive behavioral therapy (CBT) [24, 25] meant that well tolerated and effective treatments for depression and anxiety disorders became available in primary care, widening the group of individuals eligible for treatment.”
From Trends in psychiatric diagnoses, medications and psychological therapies in a large Swedish region: A population-based study (2020) · cites this paper as [23]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“there are differences in individual response”
From SSRI Treatment Response Prediction in Depression Based on Brain Activation by Emotional Stimuli (2020) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“In addition, the effect sizes are generally higher than those obtained for pharmacological treatment of mild-to-moderate depression [34]”
From One-Day Acceptance and Commitment Therapy Compared to Support for Depressed Migraine Patients: a Randomized Clinical Trial. (2020) · cites this paper as [34]
In the citing paper
“Two individual participant data meta-analysis (26, 27) indicated that patients with lower baseline severity would achieve smaller improvement compared to placebo.”
In the citing paper
“Individual-level meta-analyses have found a direct relationship between the magnitude of depressive symptoms and the effectiveness of antidepressants.8–10”
In the citing paper
“Thus, the benefits of antidepressants in non-severe depression have been argued to be minimal.8 11”
In the citing paper
“One small individual patient data meta-analysis found support for increasing benefit with increasing severity of depression,20 but three larger individual patient data meta-analyses did not find any such effect of antidepressants compared with placebo on depression severity .44–46”
From Should antidepressants be used for major depressive disorder? (2020) · cites this paper as [20]
In the citing paper
“For example, meta-analysis has demonstrated that antidepressants, though widely prescribed as a treatment for MDD, may be no more effective than placebo for mild to moderate levels of symptom severity; clinically significant benefits are only observed at “very severe” levels of impairment (18).”
From Depression in diabetes: have we been missing something important? (2011) · cites this paper as [18]
In the citing paper
“For example, meta-analysis has demonstrated that antidepressants, though widely prescribed as a treatment for MDD, may be no more effective than placebo for mild to moderate levels of symptom severity; clinically significant benefits are only observed at “very severe” levels of impairment (18).”
From Depression in diabetes: have we been missing something important? (2011) · cites this paper as [18]
In the citing paper
“Although antidepressants are unlikely to be effective in most presentations of distress (18), physical activity, psychotherapeutic approaches, and discussions with diabetes team members can be effective.”
From Depression in diabetes: have we been missing something important? (2011) · cites this paper as [18]
In the citing paper
“The strength of the pooled standardised mean difference in change was clinically important - the association between smoking cessation and change in depression and anxiety was equal to or larger than the estimate from trials of antidepressants versus placebo.”
From An application of the stress-diathesis model: A review about the association between smoking tobacco, smoking cessation, and mental health (2023) · cites this paper as Fournier et al., 2010
In the citing paper
“A meta-analysis of individual-level data from randomised controlled trials (RCTs) of antidepressants for”
From An application of the stress-diathesis model: A review about the association between smoking tobacco, smoking cessation, and mental health (2023) · cites this paper as Fournier et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. E., & Cohen, J. (1989) · Technometrics · doi:10.2307/1270020 · Cited by 99,603
Statistical power analysis for the behavioral sciences
Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,417
Statistical Power Analysis for the Behavioral Sciences (2nd ed.).
Lachenbruch, P. A., & Cohen, J. (1989) · Journal of the American Statistical Association · doi:10.2307/2290095 · Cited by 37,421
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435
Elkin, I. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110013002 · Cited by 2,300
Dimidjian, S., Hollon, S. D., Dobson, K. S., Schmaling, K. B., Kohlenberg, R. J., Addis, M. E., Gallop, R., McGlinchey, J. B., Markley, D. K., Gollan, J. K., et al. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.74.4.658 · Cited by 1,607
Self-citationOstwald, P. F. (1960) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1960.14.4.817 · Cited by 1,422
The Hamilton Depression Rating Scale: Has the Gold Standard Become a Lead Weight?
Bagby, R. M., Ryder, A. G., Schuller, D. R., & Marshall, M. B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.12.2163 · Cited by 1,148
Research works printed but not linked: 1
- [3]Depression Guideline Panel Depression in primary care: Vol. 2. Treatment of major depression Clinical Practice Guideline No. 5. AHCPR Publication No. 93-0551 Rockville, MD U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research 1993
Cited by
Sorted by citations
Items 301–400 of 1,006
ANTIDEPRESSANT ADHERENCE ACROSS DIVERSE POPULATIONS AND HEALTHCARE SETTINGS
Rossom, R. C., Shortreed, S. M., Coleman, K. J., Beck, A. L., Waitzfelder, B. E., Stewart, C. C., Ahmedani, B. K., Zeber, J. E., & Simon, G. E. (2016) · Depression and Anxiety · doi:10.1002/da.22532 · Cited by 83
Adaikkan, C., Taha, E., Barrera, I., David, O., & Rosenblum, K. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.11.028 · Cited by 79
Amato, P. R. (2014) · Family Relations · doi:10.1111/fare.12069 · Cited by 76
Beliefs about the causes of depression and treatment preferences
Khalsa, S., McCarthy, K. S., Sharpless, B. A., Barrett, M. S., & Barber, J. P. (2011) · Journal of Clinical Psychology · doi:10.1002/jclp.20785 · Cited by 76
Qiu, J., Chen, W., Gao, X., Xu, Y. J., Tong, H., Yang, M., Xiao, Z., & Yang, M. (2013) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.3109/0167482x.2013.766791 · Cited by 82
Lokkerbol, J., Adema, D., Cuijpers, P. J., Reynolds, C. F., Schulz, R., Weehuizen, R., & Smit, F. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.01.058 · Cited by 78
Clarifying domains of internalizing psychopathology using neurophysiology
Vaidyanathan, U., Nelson, L. D., & Patrick, C. J. (2011) · Psychological Medicine · doi:10.1017/s0033291711001528 · Cited by 76
Hieronymus, F., Lisinski, A., Nilsson, S., & Eriksson, E. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30216-0 · Cited by 73
Symptomatic and Functional Improvement in Employed Depressed Patients
Dunlop, B. W., Reddy, S., Yang, L., Lubaczewski, S. L., Focht, K., & Guico‐Pabia, C. J. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31822c0a68 · Cited by 75
Lemmens, L. H. J. M., Arntz, A. R., Peeters, F. P. M. L., Hollon, S. D., Roefs, A., & Huibers, M. J. H. (2015) · Psychological Medicine · doi:10.1017/s0033291715000033 · Cited by 73
Self-citationPostpartum depression: psychoneuroimmunological underpinnings and treatment
Anderson, G., & Maes, M. H. J. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s25320 · Cited by 75
Methods for Synthesizing Findings on Moderation Effects Across Multiple Randomized Trials
Prevention Science and Methodology Group, Brown, C. H., Sloboda, Z., Faggiano, F., Teasdale, B., Keller, F., Burkhart, G., Vigna‐Taglianti, F., Howe, G. W., Masyn, K. E., et al. (2011) · Prevention Science · doi:10.1007/s11121-011-0207-8 · Cited by 77
Sundbom, L. T., Bingefors, K., Hedborg, K., & Isacson, D. G. L. (2017) · BJPsych Bulletin · doi:10.1192/pb.bp.116.054270 · Cited by 82
Furukawa, T. A., Weitz, E. S., Tanaka, S., Hollon, S. D., Hofmann, S. G., Andersson, G., Twisk, J., DeRubeis, R. J., Dimidjian, S., Hegerl, U., et al. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.116.187773 · Cited by 73
Self-citationWolf, U., van Eckert, S., Walter, G., Wienke, A., Bartel, S., Plontke, S. K., & Naumann, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-99858-w · Cited by 85
Amygdala subregions tied to SSRI and placebo response in patients with social anxiety disorder
Faria, V., Appel, L., Åhs, F., Linnman, C., Pissiota, A., Frans, Ö., Bani, M., Bettica, P., Pich, E. M., Jacobsson, E., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.72 · Cited by 73
Should treatment for depression be based more on patient preference?
Winter, S., & Barber, J. (2013) · Patient Preference and Adherence · doi:10.2147/ppa.s52746 · Cited by 73
Allida, S. M., Cox, K. L., Hsieh, C., Lang, H., House, A. O., & Hackett, M. L. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003437.pub4 · Cited by 74
Wagner, S., Engel, A., Engelmann, J., Herzog, D., Dreimüller, N., Müller, M. B., Tadić, A., & Lieb, K. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.07.003 · Cited by 73
Dunlop, B. W., Thase, M. E., Wun, C., Fayyad, R. S., Guico‐Pabia, C. J., Musgnung, J. J., & Ninan, P. T. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.153 · Cited by 72
Kline, A. C., Cooper, A. A., Rytwinski, N. K., & Feeny, N. C. (2020) · Behavior Therapy · doi:10.1016/j.beth.2020.04.015 · Cited by 77
Prediction of treatment outcomes in psychiatry—where do we stand ?
McMahon, F. J. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.4/fmcmahon · Cited by 72
Stepped care treatment for depression and anxiety in primary care. a randomized controlled trial
Seekles, W., van Straten, A., Beekman, A. T. F., van Marwijk, H., & Cuijpers, P. J. (2011) · Trials · doi:10.1186/1745-6215-12-171 · Cited by 79
Biomarkers for Psychiatric Disorders: Where Are We Standing?
Martins‐de‐Souza, D. (2013) · Disease Markers · doi:10.1155/2013/321071 · Cited by 78
Stahl, S. T., Albert, S. M., Dew, M. A., Lockovich, M. H., & Reynolds, C. F. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13101373 · Cited by 71
Trambaiolli, L. R., Kohl, S. H., Linden, D. E. J., & Mehler, D. M. A. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.015 · Cited by 81
Schmauss, C. (2015) · Scientific Reports · doi:10.1038/srep08171 · Cited by 70
A Review of Longitudinal Electroconvulsive Therapy
Abbott, C., Gallegos, P., Rediske, N., Lemke, N. T., & Quinn, D. K. (2013) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988713516542 · Cited by 77
Thase, M. E., Larsen, K. G., & Kennedy, S. H. (2011) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.111.093336 · Cited by 73
Dunn, B. D., Widnall, E., Reed, N., Owens, C., Campbell, J., & Kuyken, W. (2019) · Behaviour Research and Therapy · doi:10.1016/j.brat.2019.103418 · Cited by 70
Is There Anything Really Novel on the Antidepressant Horizon?
Murrough, J. W., & Charney, D. S. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0321-8 · Cited by 70
Language Patterns Discriminate Mild Depression From Normal Sadness and Euthymic State
Smirnova, D. A., Cumming, P. D., Sloeva, E., Kuvshinova, N. Y., Romanov, D. V., & Nosachev, G. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00105 · Cited by 77
Feng, K., Shen, C., Ma, X., Chen, G., Zhang, M.-L., Xu, B., Liu, X., Sun, J., Zhang, X., Liu, P., et al. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.03.015 · Cited by 70
Buckman, J. E. J., Saunders, R., Cohen, Z. D., Barnett, P., Clarke, K., Ambler, G., DeRubeis, R. J., Gilbody, S. M., Hollon, S. D., Kendrick, T., et al. (2021) · Psychological Medicine · doi:10.1017/s0033291721001367 · Cited by 70
Self-citationChoi, W. G., Choi, W., Oh, T. J., Cha, H.-N., Hwang, I., Lee, Y. K., Lee, S. Y., Shin, H., Lim, A., Ryu, D., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145331 · Cited by 71
Efficacy of journaling in the management of mental illness: a systematic review and meta-analysis
Sohal, M., Singh, P., Dhillon, B. S., & Gill, H. S. (2022) · Family Medicine and Community Health · doi:10.1136/fmch-2021-001154 · Cited by 70
Zimmerman, M. A., Clark, H., Multach, M. D., Walsh, E. K., Rosenstein, L. K., & Gazarian, D. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.06.016 · Cited by 71
Tadić, A., Wagner, S., Schlicht, K. F., Peetz, D., Borysenko, L., Dreimüller, N., Hiemke, C., & Lieb, K. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.08.011 · Cited by 72
Almeida, O. P., Pirkis, J., Kerse, N. M., Sim, M., Flicker, L. A., Snowdon, J. A., Draper, B., Byrne, G. J., Goldney, R. D., Lautenschlager, N. T., et al. (2012) · The Annals of Family Medicine · doi:10.1370/afm.1368 · Cited by 70
Blood Transcriptomic Markers in Patients with Late-Onset Major Depressive Disorder
Miyata, S., Kurachi, M., Okano, Y., Sakurai, N., Kobayashi, A., Harada, K., Yamagata, H., Matsuo, K., Takahashi, K., Narita, K., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150262 · Cited by 71
Synaptic Regulation of a Thalamocortical Circuit Controls Depression-Related Behavior
Miller, O. H., Bruns, A., Ammar, I. B., Mueggler, T., & Hall, B. J. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.002 · Cited by 69
Kuba, K., Esser, P., Mehnert-Theuerkauf, A., Johansen, C., Schwinn, A., Schirmer, L., Schulz‐Kindermann, F., Kruse, M., Koch, U., Zander, A., et al. (2017) · Bone Marrow Transplantation · doi:10.1038/bmt.2017.190 · Cited by 68
Patel, V., Weobong, B., Nadkarni, A., Weiss, H. A., Anand, A., Naik, S., Bhat, B., Pereira, J., Araya, R., Dimidjian, S., et al. (2014) · Trials · doi:10.1186/1745-6215-15-101 · Cited by 66
Self-citationDomar, A. D., Moragianni, V. A., Ryley, D. A., & Urato, A. C. (2012) · Human Reproduction · doi:10.1093/humrep/des383 · Cited by 71
Forslund, T., Kosidou, K., Wicks, S., & Dalman, C. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02749-z · Cited by 63
Assessing the sensitivity of methods for estimating principal causal effects
Stuart, E. A., & Jo, B. (2011) · Statistical Methods in Medical Research · doi:10.1177/0962280211421840 · Cited by 71
Dunlop, B. W., LoParo, D., Kinkead, B. L., Mletzko, T., Cole, S. P., Nemeroff, C. B., Mayberg, H. S., & Craighead, W. E. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18091075 · Cited by 69
King, B. H., Dukes, K. A., Donnelly, C. L., Sikich, L., McCracken, J. T., Scahill, L. D., Hollander, E., Bregman, J. D., Anagnostou, E. A., Robinson, F., et al. (2013) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2013.2698 · Cited by 70
Results of the citalopram to enhance cognition in Huntington disease trial
Beglinger, L. J., Adams, W. H., Langbehn, D., Fiedorowicz, J. G., Jorge, R., Biglan, K., Caviness, J., Olson, B., Robinson, R. G., Kieburtz, K., et al. (2014) · Movement Disorders · doi:10.1002/mds.25750 · Cited by 65
No role for initial severity on the efficacy of antidepressants: results of a multi-meta-analysis
Fountoulakis, K. Ν., Veroniki, A. A., Siamouli, M., & Möller, H. (2013) · Annals of General Psychiatry · doi:10.1186/1744-859x-12-26 · Cited by 67
Basing psychiatric classification on scientific foundation: Problems and prospects
Uher, R., & Rutter, M. L. (2012) · International Review of Psychiatry · doi:10.3109/09540261.2012.721346 · Cited by 69
Naudet, F., Maria, A. S., & Falissard, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020811 · Cited by 70
Anand, A., Gunn, A. D., Barkay, G., Karne, H. S., Nürnberger, J. I., Mathew, S. J., & Ghosh, S. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00971.x · Cited by 69
Agomelatine versus other antidepressive agents for major depression
Guaiana, G., Gupta, S., Chiodo, D., & Davies, S. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008851 · Cited by 68
Mertens, L. J., & Preller, K. H. (2021) · Pharmacopsychiatry · doi:10.1055/a-1341-1907 · Cited by 65
Tully, P. J., Ang, S. Y., Lee, E. J., Bendig, E., Bauereiß, N., Bengel, J., & Baumeister, H. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008012.pub4 · Cited by 71
A unified model of ketamine’s dissociative and psychedelic properties
Marguilho, M., Figueiredo, I., & Castro-Rodrigues, P. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221140011 · Cited by 71
Neurobiological narratives: experiences of mood disorder through the lens of neuroimaging
Buchman, D. Z., Borgelt, E., Whiteley, L., & Illes, J. (2012) · Sociology of Health & Illness · doi:10.1111/j.1467-9566.2012.01478.x · Cited by 66
Gerger, H., Münder, T., & Barth, J. (2013) · Journal of Clinical Psychology · doi:10.1002/jclp.22059 · Cited by 65
Nakimuli‐Mpungu, E., Wamala, K., Okello, J., Alderman, S., Odokonyero, R. F., Musisi, S., & Mojtabai, R. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.03.042 · Cited by 66
The evidence-based practice of psychotherapy: Facing the challenges that lie ahead
Gaudiano, B. A., & Miller, I. W. (2013) · Clinical Psychology Review · doi:10.1016/j.cpr.2013.04.004 · Cited by 73
Nishi, D., Susukida, R., Usuda, K., Mojtabai, R., & Yamanouchi, Y. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.07.016 · Cited by 68
Lopez, R. B., Denny, B. T., & Fagundes, C. P. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.10.019 · Cited by 64
Holding the Line against Diagnostic Inflation in Psychiatry
Batstra, L., & FRANCES, A. J. (2011) · Psychotherapy and Psychosomatics · doi:10.1159/000331565 · Cited by 66
Detecting Depression Severity by Interpretable Representations of Motion Dynamics
Kacem, A., Hammal, Z., Daoudi, M., & Jeffrey, C. (2018) · International Conference on Automatic Face and Gesture Recognition · doi:10.1109/fg.2018.00116 · Cited by 64
Time and Risk Preferences, and Consumption Decisions of Patients with Clinical Depression
Bayer, Y. M., Shtudiner, Z., Suhorukov, O., & Grisaru, N. (2018) · Journal of Behavioral and Experimental Economics · doi:10.1016/j.socec.2019.01.003 · Cited by 62
RETRACTED: Individual Differences in Response to Antidepressants
Maslej, M. M., Furukawa, T. A., Cipriani, A., Andrews, P. W., & Mulsant, B. H. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.4815 · Cited by 65
RetractedA critical review of pharmacotherapy for major depressive disorder.
Dupuy, J. M., Ostacher, M. J., Huffman, J., Perlis, R. H., & Nierenberg, A. A. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000083 · Cited by 61
Taylor, S. J. C., Carnes, D., Homer, K., Kahan, B. C., Hounsome, N., Eldridge, S., Spencer, A., Pincus, T., Rahman, A., & Underwood, M. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002040 · Cited by 63
Using the Analytic Hierarchy Process to Elicit Patient Preferences
Hummel, M. J. M., Volz, F., van Manen, J. G., Danner, M., Dintsios, C., IJzerman, M. J., & Gerber, A. (2012) · Patient · doi:10.1007/bf03262495 · Cited by 63
Brog, N. A., Hegy, J. K., Berger, T., & Znoj, H. (2021) · Internet Interventions · doi:10.1016/j.invent.2021.100492 · Cited by 67
Sadler, T. W. (2011) · Reproductive Toxicology · doi:10.1016/j.reprotox.2011.09.004 · Cited by 63
Bloch, M., Meiboom, H., Lorberblat, M., Bluvstein, I., Aharonov, I., & Schreiber, S. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07117 · Cited by 63
Project INTEGRATE: An integrative study of brief alcohol interventions for college students.
Mun, E., The Project INTEGRATE Team, TORRE, J. D. L., Atkins, D. C., WHITE, H. R., Ray, A. E., Kim, S. Y., Jiao, Y., Clarke, N., Huo, Y., et al. (2014) · Psychology of Addictive Behaviors · doi:10.1037/adb0000047 · Cited by 62
Fava, G. A., Guidi, J., Rafanelli, C., & Sonino, N. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000366041 · Cited by 62
Aspirin decreases the risk of depression in older men with high plasma homocysteine
Almeida, O. P., Flicker, L. A., Yeap, B. B., Alfonso, H. S., McCaul, K. A., & Hankey, G. J. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.79 · Cited by 62
Differences in neurobiological pathways of four “clinical content” subtypes of depression
Sharpley, C. F., & Bitsika, V. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.08.030 · Cited by 63
Lorenzo-Luaces, L. (2015) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796015000542 · Cited by 55
O'Sullivan, D. T., Gordon, B. R., Lyons, M., Meyer, J. D., & Herring, M. P. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115322 · Cited by 78
Meng, X., Brunet, A., Turecki, G., Liu, A., D’Arcy, C., & Caron, J. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015156 · Cited by 62
Jodoin, V. D., Miron, J., & Lespérance, P. (2018) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.10.019 · Cited by 64
Hull, T. D., Malgaroli, M., Gazzaley, A., Akiki, T. J., Madan, A., Vando, L., Arden, K., Swain, J., Klotz, M., & Paleos, C. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.07.004 · Cited by 58
Mekonen, T., Ford, S., Chan, G., Hides, L. M., Connor, J. P., & Leung, J. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.09.046 · Cited by 60
Toward a Biological Understanding of Mortality Salience (And Other Threat Compensation Processes)
Tritt, S. M., Inzlicht, M., & Harmon-Jones, E. (2012) · Social Cognition · doi:10.1521/soco.2012.30.6.715 · Cited by 60
Psychological Problems after Stroke and Their Management: State of Knowledge
Kneebone, I., & Lincoln, N. B. (2012) · Neuroscience & Medicine · doi:10.4236/nm.2012.31013 · Cited by 59
Brimelow, R. E., Wollin, J. A., Byrne, G. J., & Dissanayaka, N. N. (2018) · International Psychogeriatrics · doi:10.1017/s1041610218001229 · Cited by 60
Are antidepressants overprescribed? Yes
Spence, D. (2013) · BMJ · doi:10.1136/bmj.f191 · Cited by 63
Rabinowitz, J., Werbeloff, N., Mandel, F. S., Ménard, F., Marangell, L. B., & Kapur, S. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.115.173906 · Cited by 59
Furukawa, T. A., Maruo, K., Noma, H., Tanaka, S., Imai, H., Shinohara, K., Ikeda, K., Yamawaki, S., Levine, S. Z., Goldberg, Y., et al. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12886 · Cited by 61
Exercise training and music therapy in elderly with depressive syndrome: A pilot study
Verrusio, W., Andreozzi, P., Marigliano, B., Renzi, A., Gianturco, V., Pecci, M. T., Ettorre, E., Cacciafesta, M., & Gueli, N. (2014) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2014.05.012 · Cited by 64
The failure of the antidepressant drug discovery process is systemic
Hendrie, C. A., & Pickles, A. R. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112466185 · Cited by 60
Rapaport, M. H., Nierenberg, A. A., Howland, R. H., Dording, C. M., Schettler, P. J., & Mischoulon, D. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.05.001 · Cited by 59
Lee, S. Y., Franchetti, M. K., Imanbayev, A., Gallo, J. J., Spira, A. P., & Lee, H. B. (2012) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2012.03.003 · Cited by 63
Amiri, S., Haj-Mirzaian, A., Momeny, M., Amini-Khoei, H., Rahimi-Balaei, M., Poursaman, S., Rastegar, M., Nikoui, V., Mokhtari, T., Ghazi-Khansari, M., et al. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2016.11.003 · Cited by 58
Drye, L. T., Martin, B. K., Frangakis, C., Meinert, C. L., Mintzer, J. E., Munro, C. A., Porsteinsson, A. P., Rabins, P. V., Rosenberg, P. B., Schneider, L. S. S., et al. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2565 · Cited by 58
A Psychoeducational Intervention (SWEEP) for Depressed Women with Diabetes
Penckofer, S. M., Ferrans, C. E., Mumby, P. B., Byrn, M. A., Emanuele, M. A., Harrison, P. R., Durazo-Arvizú, R., & Lustman, P. J. (2012) · Annals of Behavioral Medicine · doi:10.1007/s12160-012-9377-2 · Cited by 59
The Efficacy of EMDR in the Treatment of Depression
Gauhar, Y. W. M. (2016) · Journal of EMDR Practice and Research · doi:10.1891/1933-3196.10.2.59 · Cited by 58
RetractedBentley, S. M., Pagalilauan, G. L., & Simpson, S. A. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.06.013 · Cited by 66
Webb, C. A., Kertz, S. J., Bigda-Peyton, J. S., & Björgvinsson, T. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.02.016 · Cited by 55
The Effect of Antidepressants on Depression After Traumatic Brain Injury: A Meta-analysis
Kreitzer, N., Ancona, R., McCullumsmith, C., Kurowski, B. G., Foreman, B., Ngwenya, L. B., & Adeoye, O. (2019) · Journal of Head Trauma Rehabilitation · doi:10.1097/htr.0000000000000439 · Cited by 56
Metadata
- Authors
- Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., & Fawcett, J.
- Affiliations
- University of Pennsylvania (US)
- University of New Mexico (US)
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2010-01-06
- Volume
- 303
- Issue
- 1
- Pages
- 47
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC3712503
- OpenAlex
- W2004762037
- Cited by
- 2,009
- References
- 56
- Citations by year
- 2026: 54 · 2025: 72 · 2024: 89 · 2023: 70 · 2022: 81 · 2021: 134 · 2020: 81 · 2019: 111 · 2018: 143 · 2017: 128 · 2016: 112 · 2015: 149 · 2014: 154 · 2013: 170 · 2012: 172
- FWCI
- 144.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- GlaxoSmithKline
- Sanofi
- National Alliance for Research on Schizophrenia and Depression
- Universiteit Maastricht
- National Institute of Mental Health (K24MH001741, R10 MH50129, R01MH060998, K02MH001697, R10MH055875, R10MH055877)
- Janssen Pharmaceuticals
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- antidepressants, major depressive disorder, depression severity, placebo response, Hamilton Depression Rating Scale, treatment effect heterogeneity, mild depression, antidepressant efficacy
- MeSH terms
- Adult, Antidepressive Agents, Depression, Major Depressive Disorder, Humans, Placebo Effect, Randomized Controlled Trials as Topic, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
